Evidence-Based Drug Policy Act of 2025
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 3
- Latest action
- Apr 29, 2025
What it does
The Evidence-Based Drug Policy Act of 2025 would repeal a specific provision—section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998—related to drug policy oversight. This change would affect the Office of National Drug Control Policy by removing a mandated reporting or procedural requirement currently embedded in federal law. The bill aims to streamline or eliminate what its sponsors view as an outdated or unnecessary bureaucratic obligation in the realm of national drug control strategy.
AI summary · The lawmakers haven’t published an official summary of this bill yet, so 52 wrote this one from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.